WO2023057935 - LIPID NANOPARTICLE COMPRISING A NUCLEIC ACID-BINDING PROTEIN
National phase entry:
Publication Number
WO/2023/057935
Publication Date
13.04.2023
International Application No.
PCT/IB2022/059527
International Filing Date
06.10.2022
Title **
[English]
LIPID NANOPARTICLE COMPRISING A NUCLEIC ACID-BINDING PROTEIN
[French]
NANOPARTICULE LIPIDIQUE COMPRENANT UNE PROTÉINE DE LIAISON À UN ACIDE NUCLÉIQUE
Applicants **
SEQIRUS INC.
475 Green Oaks Parkway
Holly Springs, North Carolina 27540, US
Inventors
ROCKMAN, Steven
C/- Seqirus Inc.
475 Green Oaks Parkway
Holly Springs, North Carolina 27540, US
ONG, Chi
C/- Seqirus Inc.
475 Green Oaks Parkway
Holly Springs, North Carolina 27540, US
Priority Data
2021903192
06.10.2021
AU
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| * | |
International Searching Authority |
USPTO
* |
| * | |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Translation |
|
Recalculate
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing | 2076 | |
| EPO | Filing, Examination | 14915 | |
| Japan | Filing | 587 | |
| South Korea | Filing | 574 | |
| USA | Filing, Examination | 7280 |
Total: 25432 USD
The term for entry into the National Phase has expired. This quotation is for informational purposes only
Abstract[English]
The present disclosure relates to lipid nanoparticles for delivery of RNA, the lipid nanoparticle comprising therein a nucleic acid-binding protein or peptide (e.g., a RNA-binding protein or peptide) bound to the RNA, and uses thereof.[French]
La présente invention concerne des nanoparticules lipidiques destinées à l'administration d'ARN, la nanoparticule lipidique comprenant une protéine ou un peptide de liaison à un acide nucléique (par exemple, une protéine ou un peptide de liaison à l'ARN) lié(e) à l'ARN, et leurs utilisations.